Identifier |
Protein names |
Gene names |
Cross reference refseq |
Length |
Species |
A0A059RV13
|
Cytochrome c oxidase subunit 3;
|
COX3;
|
NULL
|
261
|
human
|
A0A059RS79
|
NADH-ubiquinone oxidoreductase chain 1; EC 1.6.5.3;
|
ND1;
|
NULL
|
318
|
human
|
A0A059QMS2
|
Cytochrome c oxidase subunit 1; EC 1.9.3.1;
|
COX1;
|
NULL
|
513
|
human
|
A0A067ZXH4
|
Nuclear pore complex-interacting protein; Fragment;
|
NPIP;
|
NULL
|
253
|
human
|
A0A075B6R0
|
Protein TRGV2; Fragment;
|
TRGV2;
|
NULL
|
118
|
human
|
A0A059RJI0
|
NADH-ubiquinone oxidoreductase chain 1; EC 1.6.5.3;
|
ND1;
|
NULL
|
318
|
human
|
U3MA18
|
Cytochrome c oxidase subunit 1; EC 1.9.3.1; Fragment;
|
COI;
|
NULL
|
209
|
human
|
I2B305
|
MHC class I antigen; Fragment;
|
HLA-A;
|
NULL
|
181
|
human
|
A0A059RA34
|
NADH-ubiquinone oxidoreductase chain 4; EC 1.6.5.3;
|
ND4L;
|
NULL
|
98
|
human
|
A0A059QPV3
|
Cytochrome c oxidase subunit 1; EC 1.9.3.1;
|
COX1;
|
NULL
|
513
|
human
|
A0A087WZI7
|
Anion exchange transporter;
|
SLC26A7;
|
NULL
|
355
|
human
|
A0A068BI30
|
Truncated breast and ovarian cancer susceptibility protein 2; Fragment;
|
BRCA2;
|
NULL
|
15
|
human
|
T2HKD7
|
Cytochrome c oxidase subunit 3;
|
coxIII;
|
NULL
|
262
|
human
|
A0A059QIM7
|
Cytochrome c oxidase subunit 3;
|
COX3;
|
NULL
|
261
|
human
|
I6SJA4
|
MHC class II antigen; Fragment;
|
HLA-DRB1;
|
NULL
|
89
|
human
|
A0A087WYR4
|
Immunoglobulin lambda-like polypeptide 5;
|
IGLL5;
|
NULL
|
235
|
human
|
B2R920
|
Glutathione S-transferase; EC 2.5.1.18;
|
NULL
|
NULL
|
222
|
human
|
A0A087X1T7
|
Aggrecan core protein;
|
ACAN;
|
NULL
|
2473
|
human
|
A0A087WYX1
|
Protein arginine N-methyltransferase 2;
|
PRMT2;
|
NULL
|
161
|
human
|
A0A087WVU7
|
COBW domain-containing protein 1; Fragment;
|
CBWD1;
|
NULL
|
50
|
human
|